Abstract:Background: Glioma is one of the most common and aggressive types of primary malignant tumors in the neuroectoderm, with high mortality rates, and recurrence. Immune checkpoint inhibitors have provided new insights in the treatment of tumors. Yet, there are still a lack of effective immune markers and therapeutic targets for glioma immunotherapy.Material and Methods: First, The data of glioma and corresponding clinical characteristics obtain from the CGGA database. Secondly, we calculated the abundance of immu… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.